Venus Concept PE Ratio 2016-2025 | VERO
Current and historical p/e ratio for Venus Concept (VERO) from 2016 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Venus Concept PE ratio as of May 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Venus Concept PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-20 | 2.32 | 0.00 | |
| 2025-03-31 | 2.79 | $-58.86 | 0.00 |
| 2024-12-31 | 4.14 | $-77.35 | 0.00 |
| 2024-09-30 | 6.71 | $-88.23 | 0.00 |
| 2024-06-30 | 8.61 | $-92.19 | 0.00 |
| 2024-03-31 | 7.60 | $-73.49 | 0.00 |
| 2023-12-31 | 12.98 | $-75.36 | 0.00 |
| 2023-09-30 | 21.56 | $-76.34 | 0.00 |
| 2023-06-30 | 23.10 | $-94.58 | 0.00 |
| 2023-03-31 | 36.17 | $-106.12 | 0.00 |
| 2022-12-31 | 52.80 | $-107.21 | 0.00 |
| 2022-09-30 | 72.60 | $-97.31 | 0.00 |
| 2022-06-30 | 76.53 | $-90.71 | 0.00 |
| 2022-03-31 | 235.95 | $-62.67 | 0.00 |
| 2021-12-31 | 280.50 | $-69.27 | 0.00 |
| 2021-09-30 | 414.15 | $-112.16 | 0.00 |
| 2021-06-30 | 513.15 | $-112.16 | 0.00 |
| 2021-03-31 | 387.75 | $-178.13 | 0.00 |
| 2020-12-31 | 285.45 | $-430.48 | 0.00 |
| 2020-09-30 | 382.80 | $-550.88 | 0.00 |
| 2020-06-30 | 575.85 | $-689.42 | 0.00 |
| 2020-03-31 | 585.75 | $-1,094.93 | 0.00 |
| 2019-12-31 | 775.50 | $-1,259.64 | 0.00 |
| 2019-09-30 | 1608.50 | $-1,577.71 | 0.00 |
| 2019-06-30 | 1509.75 | $-1,904.04 | 0.00 |
| 2019-03-31 | 1460.25 | $-1,953.49 | 0.00 |
| 2018-12-31 | 1078.11 | $-2,151.31 | 0.00 |
| 2018-09-30 | 7177.51 | $-1,755.67 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.065B |
| Venus Concept Inc. designs and develops medical aesthetic equipment. The company's product portfolio consists of aesthetic device platforms, including Venus Versa(TM), Venus Legacy(TM), Venus Velocity(TM), Venus Fiore(TM), Venus Viva(TM), Venus Freeze Plus(TM) and Venus Bliss(TM). It also provides NeoGraft(R), an automated hair restoration system; ARTAS(R) and ARTAS Ix(TM) Robotic Hair Restoration Systems. Venus Concept Inc., formerly known as Restoration Robotics Inc., is based in TORONTO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.696B | 87.47 |
| Thermo Fisher Scientific (TMO) | United States | $156.188B | 18.89 |
| Edwards Lifesciences (EW) | United States | $45.655B | 29.93 |
| Alcon (ALC) | Switzerland | $43.440B | 29.36 |
| IDEXX Laboratories (IDXX) | United States | $41.591B | 47.80 |
| DexCom (DXCM) | United States | $34.247B | 52.93 |
| IQVIA Holdings (IQV) | United States | $25.076B | 14.05 |
| Mettler-Toledo (MTD) | United States | $24.648B | 29.31 |
| STERIS (STE) | Ireland | $24.609B | 27.14 |
| Waters (WAT) | United States | $21.548B | 30.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.213B | 0.00 |
| Hologic (HOLX) | United States | $12.584B | 13.67 |
| Penumbra (PEN) | United States | $10.887B | 85.45 |
| Sysmex ADR (SSMXY) | Japan | $10.571B | 29.99 |
| Globus Medical (GMED) | United States | $8.473B | 19.87 |
| Masimo (MASI) | United States | $8.467B | 31.23 |
| Teleflex (TFX) | United States | $5.606B | 9.25 |
| Glaukos (GKOS) | United States | $5.571B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.243B | 22.23 |
| TransMedics (TMDX) | United States | $4.218B | 91.70 |
| PROCEPT BioRobotics (PRCT) | United States | $3.274B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.447B | 14.57 |
| Veracyte (VCYT) | United States | $2.256B | 31.66 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.058B | 23.60 |
| Alphatec Holdings (ATEC) | United States | $1.896B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.567B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.68 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.035B | 5.50 |
| SiBone (SIBN) | United States | $0.840B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| IRadimed (IRMD) | United States | $0.678B | 34.38 |
| RxSight (RXST) | United States | $0.675B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.627B | 13.70 |
| Delcath Systems (DCTH) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| NeuroPace (NPCE) | United States | $0.590B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| AxoGen (AXGN) | United States | $0.527B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.468B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| Treace Medical Concepts (TMCI) | United States | $0.421B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.386B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.229B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.122B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.099B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EDAP TMS S.A (EDAP) | France | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 17.08 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |